Department of Organic Chemistry, Medical University of Gdańsk, Al. Gen. J. Hallera 107, 80-416 Gdańsk, Poland.
Eur J Med Chem. 2012 Sep;55:384-94. doi: 10.1016/j.ejmech.2012.07.042. Epub 2012 Aug 4.
Twenty four 1-[2-alkylthio-5-(azol-2 or 5-yl)-4-chlorobenzenesulfonyl]-3-hydroxyguanidines 6a-x have been synthesized in order to evaluate their biological activity. Compounds 6a, 6c, 6d, 6f, 6g, 6i-p, 6r-t, and 6v-x were tested for their in vitro anticancer activity at the US National Cancer Institute. The highest in vitro anticancer activity was found for compounds 6d, 6g and 6k with GI(50) average value in the range 1.62-1.86 μM, and TGI mean values 3.72-4.47 μM, whereas the remaining compounds showed broad spectrum of anticancer activity at low micromolar GI(50) level against all tested cancer cell lines. These results were subjected to CoMSIA analysis to establish quantitative structure-activity relationships. The results evidence that potency of these compounds correlates mainly with hydrophobic and polar surface properties of substituents located both at 2 and 5 positions of 1-(4-chlorobenzenesulfonyl) moiety of investigated 3-hydroxyguanidine series.
为了评估它们的生物活性,合成了 24 种 1-[2-烷基硫代-5-(唑-2 或 5-基)-4-氯苯磺酰基]-3-羟基胍 6a-x。美国国立癌症研究所测试了化合物 6a、6c、6d、6f、6g、6i-p、6r-t 和 6v-x 的体外抗癌活性。化合物 6d、6g 和 6k 的体外抗癌活性最高,GI(50)平均值在 1.62-1.86 μM 范围内,TGI 平均值为 3.72-4.47 μM,而其余化合物在低微摩尔 GI(50)水平下对所有测试的癌细胞系表现出广谱抗癌活性。对这些结果进行了 CoMSIA 分析,以建立定量构效关系。结果表明,这些化合物的效力主要与位于 3-羟基胍系列中 1-(4-氯苯磺酰基)部分的 2 和 5 位取代基的疏水和极性表面积性质相关。